{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:18:37Z","timestamp":1787912317016,"version":"build-2784847793"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Science Foundation of China","award":["82090052"],"award-info":[{"award-number":["82090052"]}]},{"name":"Tsinghua University Initiative Scientific Research Program of Precision Medicine","award":["2022ZLA007"],"award-info":[{"award-number":["2022ZLA007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00820-1","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:10:40Z","timestamp":1787911840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial multi omic profiling maps hypoxia-driven pro-fibrotic SPP1+ macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Fansen","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"820_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158:410\u201320. https:\/\/doi.org\/10.1001\/jamasurg.2022.7989.","journal-title":"JAMA Surg"},{"key":"820_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:1\u201328. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"key":"820_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20:864\u201384. https:\/\/doi.org\/10.1038\/s41571-023-00825-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"820_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76:681\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.018.","journal-title":"J Hepatol"},{"key":"820_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","volume":"18","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:293\u2013313. https:\/\/doi.org\/10.1038\/s41575-020-00395-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"820_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000367743","volume":"4","author":"T Arizumi","year":"2015","unstructured":"Arizumi T, Ueshima K, Minami T, Kono M, Chishina H, Takita M, et al. Effectiveness of sorafenib in patients with transcatheter arterial chemoembolization (TACE) refractory and intermediate-stage hepatocellular carcinoma. Liver Cancer (Basel). 2015;4:253\u201362. https:\/\/doi.org\/10.1159\/000367743.","journal-title":"Liver Cancer (Basel)"},{"key":"820_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000507370","volume":"9","author":"M Kudo","year":"2020","unstructured":"Kudo M, Han K-H, Ye S-L, Zhou J, Huang Y-H, Lin S-M, et al. A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements. Liver Cancer (Basel). 2020;9:245\u201360. https:\/\/doi.org\/10.1159\/000507370.","journal-title":"Liver Cancer (Basel)"},{"key":"820_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jhep.2015.02.010","volume":"62","author":"W Sieghart","year":"2015","unstructured":"Sieghart W, Hucke F, Peck-Radosavljevic M. Transarterial chemoembolization: modalities, indication, and patient selection. J Hepatol. 2015;62:1187\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.010.","journal-title":"J Hepatol"},{"key":"820_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01235-0","volume":"8","author":"H-D Zhu","year":"2023","unstructured":"Zhu H-D, Li H-L, Huang M-S, Yang W-Z, Yin G-W, Zhong B-Y, Sun J-H, Jin Z-C, Chen J-J, Ge N-J, et al. Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Sig Transduct Target Ther. 2023;8:1\u201310. https:\/\/doi.org\/10.1038\/s41392-022-01235-0.","journal-title":"Sig Transduct Target Ther"},{"key":"820_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102622","volume":"72","author":"Z-C Jin","year":"2024","unstructured":"Jin Z-C, Chen J-J, Zhu X-L, Duan X-H, Xin Y-J, Zhong B-Y, et al. Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody\/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study. EClinicalMedicine. 2024;72:102622. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102622.","journal-title":"EClinicalMedicine"},{"key":"820_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(24)02551-0","volume":"405","author":"B Sangro","year":"2025","unstructured":"Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, et al. Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study. Lancet. 2025;405:216\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(24)02551-0.","journal-title":"Lancet"},{"key":"820_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(24)02575-3","volume":"405","author":"M Kudo","year":"2025","unstructured":"Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, et al. Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study. Lancet. 2025;405:203\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(24)02575-3.","journal-title":"Lancet"},{"key":"820_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.032","author":"J Tan","year":"2023","unstructured":"Tan J, Fan W, Liu T, Zhu B, Liu Y, Wang S, Wu J, Liu J, Zou F, Wei J, et al. TREM2\u2009+\u2009macrophages suppress CD8\u2009+\u2009T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. J Hepatol. 2023. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.032.","journal-title":"J Hepatol"},{"key":"820_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000548","volume":"8","author":"L Wang","year":"2024","unstructured":"Wang L, Cao J, Liu Z, Wu S, Liu Y, Liang R, et al. Enhanced interactions within microenvironment accelerates dismal prognosis in HBV-related HCC after TACE. Hepatol Commun. 2024;8:e0548. https:\/\/doi.org\/10.1097\/HC9.0000000000000548.","journal-title":"Hepatol Commun"},{"key":"820_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, Sun L, Liu Y, Du Y, Guo X, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78:770\u201382. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.011.","journal-title":"J Hepatol"},{"key":"820_CR16","doi-asserted-by":"publisher","unstructured":"Qiu X, Zhou T, Li S, Wu J, Tang J, Ma G, Yang S, Hu J, Wang K, Shen S, et al. Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma. Nat Cancer. 2024;1\u201322. https:\/\/doi.org\/10.1038\/s43018-024-00824-y.","DOI":"10.1038\/s43018-024-00824-y"},{"key":"820_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41586-025-08668-x","volume":"640","author":"G Jia","year":"2025","unstructured":"Jia G, He P, Dai T, Goh D, Wang J, Sun M, et al. Spatial immune scoring system predicts hepatocellular carcinoma recurrence. Nature. 2025;640:1031\u201341. https:\/\/doi.org\/10.1038\/s41586-025-08668-x.","journal-title":"Nature"},{"key":"820_CR18","unstructured":"Xie A, Wang H, Zhao J, Wang Z, Xu J, Xu Y. scPAS: single-cell phenotype-associated subpopulation identifier."},{"key":"820_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382. https:\/\/doi.org\/10.1038\/s41587-019-0114-2.","journal-title":"Nat Biotechnol"},{"key":"820_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwab192","volume":"9","author":"W Zhai","year":"2022","unstructured":"Zhai W, Lai H, Kaya NA, Chen J, Yang H, Lu B, et al. Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study. Natl Sci Rev. 2022;9:nwab192. https:\/\/doi.org\/10.1093\/nsr\/nwab192.","journal-title":"Natl Sci Rev"},{"key":"820_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert M, Klinger B, Kl\u00fcnemann M, Sieber A, Uhlitz F, Sauer S, et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun. 2018;9:20. https:\/\/doi.org\/10.1038\/s41467-017-02391-6.","journal-title":"Nat Commun"},{"key":"820_CR22","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1093\/nar\/gkad841","volume":"51","author":"S M\u00fcller-Dott","year":"2023","unstructured":"M\u00fcller-Dott S, Tsirvouli E, Vazquez M, Ramirez Flores RO, Badia-i-Mompel P, Fallegger R, et al. Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities. Nucleic Acids Res. 2023;51:10934\u201349. https:\/\/doi.org\/10.1093\/nar\/gkad841.","journal-title":"Nucleic Acids Res"},{"key":"820_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp4942","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yu B, Ming W, Zhou X, Wang J, Chen D. SpaTopic: A statistical learning framework for exploring tumor spatial architecture from spatially resolved transcriptomic data. Sci Adv. 2024. https:\/\/doi.org\/10.1126\/sciadv.adp4942.","journal-title":"Sci Adv"},{"key":"820_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","volume":"609","author":"C Tsui","year":"2022","unstructured":"Tsui C, Kretschmer L, Rapelius S, Gabriel SS, Chisanga D, Kn\u00f6pper K, et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature. 2022;609:354\u201360. https:\/\/doi.org\/10.1038\/s41586-022-05105-1.","journal-title":"Nature"},{"key":"820_CR25","doi-asserted-by":"publisher","unstructured":"Kersten K, Hu KH, Combes AJ, Samad B, Harwin T, Ray A, Rao AA, Cai E, Marchuk K, Artichoker J, Courau T. Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer. Cancer cell. 2022;40. https:\/\/doi.org\/10.1016\/j.ccell.2022.05.004.","DOI":"10.1016\/j.ccell.2022.05.004"},{"key":"820_CR26","doi-asserted-by":"publisher","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6:e1792\u20131792. https:\/\/doi.org\/10.1038\/cddis.2015.162.","journal-title":"Cell Death Dis"},{"key":"820_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ccell.2025.01.001","volume":"43","author":"X Guo","year":"2025","unstructured":"Guo X, Nie H, Zhang W, Li J, Ge J, Xie B, Hu W, Zhu Y, Zhong N, Zhang X, et al. Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer. Cancer Cell. 2025;43:248\u2013e2689. https:\/\/doi.org\/10.1016\/j.ccell.2025.01.001.","journal-title":"Cancer Cell"},{"issue":"1","key":"820_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1\u2009+\u2009macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742. https:\/\/doi.org\/10.1038\/s41467-022-29366-6.","journal-title":"Nat Commun"},{"key":"820_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41141-9","volume":"14","author":"S Sch\u00fctz","year":"2023","unstructured":"Sch\u00fctz S, Sol\u00e9-Boldo L, Lucena-Porcel C, Hoffmann J, Brobeil A, Lonsdorf AS, et al. Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma. Nat Commun. 2023;14:5413. https:\/\/doi.org\/10.1038\/s41467-023-41141-9.","journal-title":"Nat Commun"},{"key":"820_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112131","volume":"42","author":"K Hoeft","year":"2023","unstructured":"Hoeft K, Schaefer GJL, Kim H, Schumacher D, Bleckwehl T, Long Q, et al. Platelet-instructed SPP1\u2009+\u2009macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner. Cell Rep. 2023;42:112131. https:\/\/doi.org\/10.1016\/j.celrep.2023.112131.","journal-title":"Cell Rep"},{"key":"820_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","volume":"23","author":"F-T Liu","year":"2023","unstructured":"Liu F-T, Stowell SR. The role of galectins in immunity and infection. Nat Rev Immunol. 2023;23:479\u201394. https:\/\/doi.org\/10.1038\/s41577-022-00829-7.","journal-title":"Nat Rev Immunol"},{"key":"820_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/j.gastro.2024.03.007","volume":"167","author":"D Yang","year":"2024","unstructured":"Yang D, Sun X, Moniruzzaman R, Wang H, Citu C, Zhao Z, Wistuba II, Wang H, Maitra A, Chen Y. Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. Gastroenterology. 2024;167:298\u2013314. https:\/\/doi.org\/10.1053\/j.gastro.2024.03.007.","journal-title":"Gastroenterology"},{"key":"820_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","volume":"131","author":"K Takayasu","year":"2006","unstructured":"Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2006.05.021.","journal-title":"Gastroenterology"},{"key":"820_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202206","volume":"9","author":"C Zhong","year":"2022","unstructured":"Zhong C, Niu Y, Liu W, Yuan Y, Li K, Shi Y, et al. S100A9 derived from chemoembolization-induced hypoxia governs mitochondrial function in hepatocellular carcinoma progression. Adv Sci (Weinh). 2022;9:e2202206. https:\/\/doi.org\/10.1002\/advs.202202206.","journal-title":"Adv Sci (Weinh)"},{"key":"820_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105436","volume":"109","author":"L Song","year":"2024","unstructured":"Song L, Zhu C, Shi Q, Xia Y, Liang X, Qin W, et al. Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progression. EBioMedicine. 2024;109:105436. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105436.","journal-title":"EBioMedicine"},{"key":"820_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-024-00564-3","volume":"8","author":"G Fan","year":"2024","unstructured":"Fan G, Xie T, Li L, Tang L, Han X, Shi Y. Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1\u2009+\u2009macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma. npj Precis Onc. 2024;8:1\u201316. https:\/\/doi.org\/10.1038\/s41698-024-00564-3.","journal-title":"npj Precis Onc"},{"key":"820_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12967-025-06444-z","volume":"23","author":"Y Tan","year":"2025","unstructured":"Tan Y, Yang Y-G, Zhang X, Zhao L, Wang X, Liu W. Tumor cell-derived osteopontin promotes tumor fibrosis indirectly via tumor-associated macrophages. J Translational Med. 2025;23:432. https:\/\/doi.org\/10.1186\/s12967-025-06444-z.","journal-title":"J Translational Med"},{"key":"820_CR38","doi-asserted-by":"publisher","unstructured":"Wei T, Wang K, Liu S, Fang Y, Hong Z, Liu Y, Zhang H, Yang C, Ouyang G, Wu T. Periostin deficiency reduces PD-1+ tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer. Cell Reports. 2023;42(2). https:\/\/doi.org\/10.1016\/j.celrep.2023.112090.","DOI":"10.1016\/j.celrep.2023.112090"},{"key":"820_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01717-y","volume":"18","author":"Q Hu","year":"2025","unstructured":"Hu Q, Zhu Y, Mei J, Liu Y, Zhou G. Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy. J Hematol Oncol. 2025;18:65. https:\/\/doi.org\/10.1186\/s13045-025-01717-y.","journal-title":"J Hematol Oncol"},{"key":"820_CR40","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1158\/0008-5472.CAN-23-0783","volume":"83","author":"Y Fan","year":"2023","unstructured":"Fan Y, Song S, Li Y, Dhar SS, Jin J, Yoshimura K, Yao X, Wang R, Scott AW, Pizzi MP, et al. Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Res. 2023;83:3726\u201338. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0783.","journal-title":"Cancer Res"},{"key":"820_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2019.101010","volume":"76","author":"RC Gilson","year":"2019","unstructured":"Gilson RC, Gunasinghe SD, Johannes L, Gaus K. Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling. Prog Lipid Res. 2019;76:101010. https:\/\/doi.org\/10.1016\/j.plipres.2019.101010.","journal-title":"Prog Lipid Res"},{"key":"820_CR42","doi-asserted-by":"publisher","unstructured":"Chen Y, Jiang Q, Xing X, Xu L, Zhao Q, Zhang Q, Chen J, Ma C, Liu X, Lu Y, et al. Macrophage Derived Galectin-3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGF\u03b21 Signaling. Adv Sci (Weinh). 2025;e04032. https:\/\/doi.org\/10.1002\/advs.202504032.","DOI":"10.1002\/advs.202504032"},{"key":"820_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58748-9","volume":"16","author":"A Harada","year":"2025","unstructured":"Harada A, Yasumizu Y, Harada T, Fumoto K, Sato A, Maehara N, et al. Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression. Nat Commun. 2025;16:3653. https:\/\/doi.org\/10.1038\/s41467-025-58748-9.","journal-title":"Nat Commun"},{"key":"820_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jare.2023.09.004","volume":"61","author":"K Yang","year":"2024","unstructured":"Yang K, Zhao Y, Hu J, Gao R, Shi J, Wei X, Chen J, Hu K, Sun A, Ge J. ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction. J Adv Res. 2024;61:193\u2013209. https:\/\/doi.org\/10.1016\/j.jare.2023.09.004.","journal-title":"J Adv Res"},{"key":"820_CR45","doi-asserted-by":"publisher","first-page":"101815","DOI":"10.1016\/j.redox.2020.101815","volume":"38","author":"Q Wang","year":"2021","unstructured":"Wang Q, Wang P, Qin Z, Yang X, Pan B, Nie F, Bi H. Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia. Redox Biol. 2021;38:101815. https:\/\/doi.org\/10.1016\/j.redox.2020.101815.","journal-title":"Redox Biol"},{"key":"820_CR46","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.immuni.2021.04.021","volume":"54","author":"MB Buechler","year":"2021","unstructured":"Buechler MB, Fu W, Turley SJ. Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer. Immunity. 2021;54:903\u201315. https:\/\/doi.org\/10.1016\/j.immuni.2021.04.021.","journal-title":"Immunity"},{"key":"820_CR47","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60:1090\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2013.12.025.","journal-title":"J Hepatol"},{"key":"820_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02247-1","volume":"10","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Cai R, Huang Y, Zhu L, Xiao L, Wang C, et al. Macrophages in organ fibrosis: from pathogenesis to therapeutic targets. Cell Death Discov. 2024;10:487. https:\/\/doi.org\/10.1038\/s41420-024-02247-1.","journal-title":"Cell Death Discov"},{"key":"820_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI193793","volume":"135","author":"M Wang","year":"2025","unstructured":"Wang M, Chu X, Fan Z, Chen L, Wang H, Wang P, et al. Macrophage transition to a myofibroblast state drives fibrotic disease in uropathogenic E. coli-induced epididymo-orchitis. J Clin Invest. 2025;135:e193793. https:\/\/doi.org\/10.1172\/JCI193793.","journal-title":"J Clin Invest"},{"key":"820_CR50","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-024-46357-x","volume":"15","author":"T Zhuang","year":"2024","unstructured":"Zhuang T, Chen M-H, Wu R-X, Wang J, Hu X-D, Meng T, Wu A-H, Li Y, Yang Y-F, Lei Y, et al. ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice. Nat Commun. 2024;15:1995. https:\/\/doi.org\/10.1038\/s41467-024-46357-x.","journal-title":"Nat Commun"},{"key":"820_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10859-w","volume":"10","author":"H Abe","year":"2019","unstructured":"Abe H, Takeda N, Isagawa T, Semba H, Nishimura S, Morioka MS, et al. Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M. Nat Commun. 2019;10:2824. https:\/\/doi.org\/10.1038\/s41467-019-10859-w.","journal-title":"Nat Commun"},{"key":"820_CR52","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jhep.2019.01.027","volume":"70","author":"TF Greten","year":"2019","unstructured":"Greten TF, Mauda-Havakuk M, Heinrich B, Korangy F, Wood BJ. Combined locoregional-immunotherapy for liver cancer. J Hepatol. 2019;70:999\u20131007. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.027.","journal-title":"J Hepatol"},{"key":"820_CR53","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1158\/1078-0432.CCR-19-2300","volume":"26","author":"JS Bergholz","year":"2020","unstructured":"Bergholz JS, Wang Q, Kabraji S, Zhao JJ. Integrating immunotherapy and targeted therapy in cancer treatment: mechanistic insights and clinical implications. Clin cancer research: official J Am Association Cancer Res. 2020;26:5557. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2300.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"1","key":"820_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00662-1","volume":"12","author":"H Xu","year":"2024","unstructured":"Xu H, Chai H, Chen M, Zhu R, Jiang S, Liu X, et al. Single-cell RNA sequencing identifies a subtype of FN1\u2009+\u2009tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy. Biomark Res. 2024;12(1):114. https:\/\/doi.org\/10.1186\/s40364-024-00662-1.","journal-title":"Biomark Res"},{"key":"820_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18546-x","volume":"11","author":"D Xiong","year":"2020","unstructured":"Xiong D, Wang Y, You M. A gene expression signature of TREM2hi macrophages and \u03b3\u03b4 T cells predicts immunotherapy response. Nat Commun. 2020;11:5084. https:\/\/doi.org\/10.1038\/s41467-020-18546-x.","journal-title":"Nat Commun"},{"key":"820_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05624-7","volume":"22","author":"Y-Z Zhang","year":"2024","unstructured":"Zhang Y-Z, Wu Y, Li M, Mijiti A, Cheng L-F. Identification of macrophage driver genes in fibrosis caused by different heart diseases based on omics integration. J Transl Med. 2024;22:839. https:\/\/doi.org\/10.1186\/s12967-024-05624-7.","journal-title":"J Transl Med"},{"key":"820_CR57","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.immuni.2026.04.001","volume":"59","author":"L Sun","year":"2026","unstructured":"Sun L, Chu X, Kong T, Chen X, Ru J, Gao Q, Zhou W, Wang X, Cheng S, Zhu L, et al. An SPP1-SOCS1 pathway constrains interferon responses in tumor-associated macrophages and shapes an immunosuppressive tumor microenvironment. Immunity. 2026;59:1422\u2013e14379. https:\/\/doi.org\/10.1016\/j.immuni.2026.04.001.","journal-title":"Immunity"},{"key":"820_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1606195","volume":"15","author":"W-X Xu","year":"2025","unstructured":"Xu W-X, Ye Y-M, Chen J-L, Guo X-Y, Li C, Luo J, et al. SPP1\u2009+\u2009tumor-associated macrophages define a high-risk subgroup and inform personalized therapy in hepatocellular carcinoma. Front Oncol. 2025;15:1606195. https:\/\/doi.org\/10.3389\/fonc.2025.1606195.","journal-title":"Front Oncol"},{"key":"820_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/ijog\/5555332","volume":"2025","author":"S Yue","year":"2025","unstructured":"Yue S, Ding Q, Tan S, Zhang P. SPP1\u2009+\u2009macrophage-associated prognostic signature in hepatocellular carcinoma via integrated single-cell and bulk transcriptomic analysis. Int J Genomics. 2025;2025:5555332. https:\/\/doi.org\/10.1155\/ijog\/5555332.","journal-title":"Int J Genomics"},{"key":"820_CR60","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cyto.2013.07.021","volume":"64","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Jang JW, Oh BS, Kwon JH, Chung KW, Jung HS, et al. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma. Cytokine. 2013;64:516\u201322. https:\/\/doi.org\/10.1016\/j.cyto.2013.07.021.","journal-title":"Cytokine"},{"key":"820_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.actbio.2022.12.004","volume":"157","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Ma M, Han X, Li X, Huang J, Zhao Y, Liu H, Kang J, Kong X, Sun G, et al. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma. Acta Biomater. 2023;157:337\u201351. https:\/\/doi.org\/10.1016\/j.actbio.2022.12.004.","journal-title":"Acta Biomater"},{"key":"820_CR62","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jhep.2025.10.008","volume":"84","author":"R Li","year":"2026","unstructured":"Li R, Liu J, Ye F, He S, Huang J, Zhou M, et al. Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC. J Hepatol. 2026;84:808\u201322. https:\/\/doi.org\/10.1016\/j.jhep.2025.10.008.","journal-title":"J Hepatol"},{"key":"820_CR63","doi-asserted-by":"publisher","unstructured":"Jiang N, Pei Z, Gong F, Yang W, Xu J, Cao J, Pan X, Yu B, Shen J, Li Z, et al. Dual-targeted microspheres reshape the metabolic-immune microenvironment to reverse post-embolization dilemmas in hepatocellular carcinoma. Cell Rep Med. 2026;102748. https:\/\/doi.org\/10.1016\/j.xcrm.2026.102748.","DOI":"10.1016\/j.xcrm.2026.102748"},{"key":"820_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02988-9","volume":"24","author":"Q Li","year":"2023","unstructured":"Li Q. ScTour: a deep learning architecture for robust inference and accurate prediction of cellular dynamics. Genome Biol. 2023;24:149. https:\/\/doi.org\/10.1186\/s13059-023-02988-9.","journal-title":"Genome Biol"},{"key":"820_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, Katz R, Himmelfarb J, Bansal N, Lee S-I. From Local Explanations to Global Understanding with Explainable AI for Trees. Nat Mach Intell. 2020;2:56\u201367. https:\/\/doi.org\/10.1038\/s42256-019-0138-9.","journal-title":"Nat Mach Intell"},{"key":"820_CR66","doi-asserted-by":"publisher","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"P Badia-I-Mompel","year":"2022","unstructured":"Badia-I-Mompel P, V\u00e9lez Santiago J, Braunger J, Geiss C, Dimitrov D, M\u00fcller-Dott S, Taus P, Dugourd A, Holland CH, Ramirez Flores RO, et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv. 2022;2:vbac016. https:\/\/doi.org\/10.1093\/bioadv\/vbac016.","journal-title":"Bioinform Adv"},{"key":"820_CR67","doi-asserted-by":"publisher","unstructured":"Peng X, Smithy JW, Yosofvand M, Kostrzewa CE, Bleile M, Ehrich FD, Lee J, Postow MA, Callahan MK, Panageas KS, et al. Decoding Spatial Tissue Architecture: A Scalable Bayesian Topic Model for Multiplexed Imaging Analysis. bioRxiv. 2024;20241008617293. https:\/\/doi.org\/10.1101\/2024.10.08.617293.","DOI":"10.1101\/2024.10.08.617293"},{"key":"820_CR68","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"820_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0694-x","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yu X, Zheng L, Zhang Y, Li Y, Fang Q, Gao R, Kang B, Zhang Q, Huang JY, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018. https:\/\/doi.org\/10.1038\/s41586-018-0694-x.","journal-title":"Nature"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00820-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:10:42Z","timestamp":1787911842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00820-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00820-1","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FFPE tissue specimens were retrospectively collected from four patients with HCC who received TACE treatment followed by surgical resection at the Department of Pathology, Beijing Tsinghua Changgung Hospital. The study protocol was reviewed and approved by the Ethics Committee of Beijing Tsinghua Changgung Hospital, Tsinghua University (Approval No. 25521-0-02), and written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"82"}}